Satavari Ghrita: What It Is, Classical Uses & the Evidence
TL;DR
Satavari ghrita is a classical Ayurvedic medicated ghee built around shatavari (Asparagus racemosus). Classical texts prescribe it for vata disorders such as gout and neurological conditions: but no clinical trials have tested the finished formulation. The shatavari ingredient has RCT support for menopausal symptoms; that evidence does not automatically transfer to the ghee.
What it is
Satavari ghrita (also spelled shatavari ghrita) is a classical Ayurvedic medicated ghee: a preparation in which herbs are cooked into clarified butter (ghee). Shatavari (Asparagus racemosus Willd., the tuberous root) is the principal ingredient. It is identified in the claim bank as a herb of the Asparagaceae family rich in steroidal saponins called shatavarins (Patibandla et al., Front Pharmacol 2024).
A standardization study describes the classical sneha-paka method used for this ghrita: ghee, herbal paste (kalka), and decoction (kwatha) in a 1 : 1/4 : 4 ratio, heated gently until the water evaporates and only the medicated ghee remains (standardization study, IJCRM). Later formularies describe related variants: e.g., shatavaryadi ghrita in the Sahasrayoga tradition, that add herbs such as gokshura, vidari, and licorice. Naming varies across sources, this database treats "shatavaryadi ghrita" as another name for shatavari ghrita, so the recipe behind any given product should be checked against its label or formulary reference (medicinal-plants database).
Traditional use
Classical references, presented here as tradition: not clinical proof:
- Ashtanga Samgraha, Chikitsasthana 24/4 (the chapter on vatarakta/gout): "when vata is predominant, the patient should be made to drink old ghee or satavari ghrita" (English rendering of the verse).
- Bhaishajya Ratnavali 82/18 lists shatavari ghrita for snayu roga (disorders of the nerves, muscles, and tendons) (tabulated in WJPMR 2025).
- Charaka Samhita's formulary index lists shatavari ghrita at Chikitsa 19/97, naming shatavari among its ingredients (Charaka Samhita Online).
What modern research says
Clinical trials of the finished formulation: none found
A search of PubMed/PMC found no published clinical trials testing satavari ghrita itself. Every human study located tested shatavari root extracts or powders: not the medicated ghee. This is the central evidence gap for this article.
What the shatavari ingredient studies show (not the ghrita)
- Perimenopause RCT (Mahajan et al. 2025): n=80 perimenopausal women; 300 mg/day of a standardized shatavari root extract (SRI-81) for 8 weeks reduced total Menopause Rating Scale scores by 42.6% versus 5.5% for placebo. No adverse events were reported and liver/kidney markers stayed stable (Int J Womens Health).
- Second perimenopause RCT: n=150 perimenopausal women; 500 mg/day of another proprietary extract (Aspurus) for 12 weeks significantly improved symptom scores versus placebo; the trial was industry-sponsored (J Diet Suppl 2026).
- 24-week RCT: in postmenopausal women, shatavari-only arms (250 and 500 mg/day) showed dose-dependent improvements in menopause-specific quality of life versus placebo (PMC12070120).
Scope caution: all three trials used proprietary standardized extracts: not generic root powder, and not a ghee formulation (Ixoreal's proprietary extract in Mahajan et al. 2025; Waleria's patented Aspurus in the J Diet Suppl trial; a >30%-saponin standardized extract in the 24-week trial). Ingredient results do not automatically transfer to satavari ghrita.
Dosage
No pharmacopoeial or clinical-trial dose for satavari ghrita itself could be verified. Dosages quoted on commercial websites are marketing copy, not evidence: this article's title deliberately makes no dosage promise. Ask a qualified practitioner.
Safety & contraindications
No dedicated safety studies of the finished formulation were found in the sources reviewed. In the two shorter ingredient trials (8–12 weeks), no adverse events were reported, and liver/kidney markers stayed stable in the 8-week trial. Longer-term human safety data for shatavari are limited (Mahajan et al. 2025; Aspurus trial, J Diet Suppl). Anyone who is pregnant, breastfeeding, or managing a metabolic or hormonal condition should consult a clinician before use.
FAQs
What is satavari ghrita?
A classical Ayurvedic medicated ghee built around shatavari root, prepared by the sneha-paka method: ghee, herbal paste, and decoction cooked together until only medicated ghee remains (standardization study).
What is satavari ghrita traditionally used for?
Classical texts prescribe it for vata-predominant disorders: vatarakta (gout) in the Ashtanga Samgraha and snayu roga (nerve/muscle disorders) in the Bhaishajya Ratnavali (verse rendering; WJPMR 2025). These are classical indications, not proven effects.
Is there clinical evidence for satavari ghrita?
No clinical trials of the finished formulation were found. The human trials that exist tested shatavari root extracts (not the ghee) for menopausal symptoms: e.g., an 8-week RCT of 300 mg/day in 80 perimenopausal women (Int J Womens Health).
How is satavari ghrita different from shatavari powder?
Shatavari powder is the raw root; satavari ghrita is a classical fat-based preparation of which the root is the principal ingredient. Related variant recipes (e.g., shatavaryadi ghrita) add further herbs; sources differ on whether the names denote the same product or distinct recipes, so check the label (medicinal-plants database).
Is satavari ghrita safe?
No formulation-specific safety data exist. The ingredient trials (8–24 weeks) reported no adverse events, but longer-term data are limited: consult a qualified practitioner, especially if pregnant, breastfeeding, or managing a metabolic condition.
Sources
- Ashtanga Samgraha, Chikitsasthana Ch. 24 (vatarakta) — English rendering of the verses — pocketayurveda.com
- Charaka Samhita Online — Shatavari index (incl. shatavari ghrita, Chikitsa 19/97) — carakasamhitaonline.com
- Classical formulation tabulation incl. Bhaishajya Ratnavali references — WJPMR 2025 — wjpmr.com
- Standardization study of Shatavari Ghrita (sneha-paka method, IJCRM) — zenodo.org
- Shatavaryadi Ghritam — related variant formula (Sahasrayoga reference) — medicinalplantsindia.com
- Mahajan S et al. "Shatavari root extract (SRI-81) in perimenopausal women: randomized controlled trial." Int J Womens Health. 2025 — DOI · 10.2147/IJWH.S544267
- "Shatavari root extract (Aspurus) in perimenopausal women: randomized controlled trial." J Diet Suppl. 2026 — tandfonline.com
- 24-week shatavari RCT in postmenopausal women — PMC · PMC12070120
- Patibandla R et al. "Shatavari: a comprehensive review." Front Pharmacol. 2024 (identity/constituents) — PMC · PMC10981444
Related herbs
Disclaimer
This content is for education, not medical advice. Consult your doctor before using any herb, especially if you're pregnant, breastfeeding, or taking prescription medication.